257 related articles for article (PubMed ID: 35062337)
1. GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition.
Bestion E; Zandi K; Belouzard S; Andreani J; Lepidi H; Novello M; Rouquairol C; Baudoin JP; Rachid M; La Scola B; Mege JL; Dubuisson J; Schinazi RF; Mezouar S; Halfon P
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062337
[TBL] [Abstract][Full Text] [Related]
2. GNS561 exhibits potent
Halfon P; Bestion E; Zandi K; Andreani J; Baudoin JP; La Scola B; Mege JL; Mezouar S; Schinazi RF
bioRxiv; 2020 Oct; ():. PubMed ID: 33052342
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues.
Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Li N; Tian M; Jin N; Li X
J Virol; 2021 Nov; 95(24):e0153721. PubMed ID: 34550769
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
Boon ACM; Bricker TL; Fritch EJ; Leist SR; Gully K; Baric RS; Graham RL; Troan BV; Mahoney M; Janetka JW
J Virol; 2024 May; 98(5):e0190323. PubMed ID: 38593045
[TBL] [Abstract][Full Text] [Related]
6. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
[TBL] [Abstract][Full Text] [Related]
7. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication.
Chu J; Xing C; Du Y; Duan T; Liu S; Zhang P; Cheng C; Henley J; Liu X; Qian C; Yin B; Wang HY; Wang RF
Nat Metab; 2021 Nov; 3(11):1466-1475. PubMed ID: 34580494
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model.
Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Seibert B; Rajao DS; Wang J; Perez DR
Sci Rep; 2021 May; 11(1):9609. PubMed ID: 33953295
[TBL] [Abstract][Full Text] [Related]
10. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine.
Bonam SR; Muller S; Bayry J; Klionsky DJ
Autophagy; 2020 Dec; 16(12):2260-2266. PubMed ID: 32522067
[TBL] [Abstract][Full Text] [Related]
11. Coronaviruses construct an interconnection way with ERAD and autophagy.
Movaqar A; Yaghoubi A; Rezaee SR; Jamehdar SA; Soleimanpour S
Future Microbiol; 2021 Sep; 16(14):1135-1151. PubMed ID: 34468179
[TBL] [Abstract][Full Text] [Related]
12. Activity of Galidesivir in a Hamster Model of SARS-CoV-2.
Taylor R; Bowen R; Demarest JF; DeSpirito M; Hartwig A; Bielefeldt-Ohmann H; Walling DM; Mathis A; Babu YS
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062212
[TBL] [Abstract][Full Text] [Related]
13. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
[TBL] [Abstract][Full Text] [Related]
15. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
Morris G; Athan E; Walder K; Bortolasci CC; O'Neil A; Marx W; Berk M; Carvalho AF; Maes M; Puri BK
Life Sci; 2020 Dec; 262():118541. PubMed ID: 33035581
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals.
Gassen NC; Papies J; Bajaj T; Emanuel J; Dethloff F; Chua RL; Trimpert J; Heinemann N; Niemeyer C; Weege F; Hönzke K; Aschman T; Heinz DE; Weckmann K; Ebert T; Zellner A; Lennarz M; Wyler E; Schroeder S; Richter A; Niemeyer D; Hoffmann K; Meyer TF; Heppner FL; Corman VM; Landthaler M; Hocke AC; Morkel M; Osterrieder N; Conrad C; Eils R; Radbruch H; Giavalisco P; Drosten C; Müller MA
Nat Commun; 2021 Jun; 12(1):3818. PubMed ID: 34155207
[TBL] [Abstract][Full Text] [Related]
18. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
19. Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19.
He W; Gao Y; Zhou J; Shi Y; Xia D; Shen HM
Int J Biol Sci; 2022; 18(12):4690-4703. PubMed ID: 35874956
[TBL] [Abstract][Full Text] [Related]
20. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
